0
0
40 words
0
Comments
The treatment combined adoptive T-cell therapy with a personalized cancer vaccine and was found to be safe in a small cohort of 17 patients.
You are the first to view
https://www.ajmc.com/view/innovative-combination-therapy-shows-promise-for-late-stage-ovarian-cancer
Create an account or login to join the discussion